Most enterprise R&D environments were not designed as a coherent system.
They were assembled over time.
An ELN was introduced for research documentation. A LIMS was purchased for sample and test management. A QMS was added for deviations, CAPAs, and controlled documents. A PLM system was deployed for product definitions and changes. ERP retained material, supplier, inventory, and cost information. Spreadsheets filled the gaps between them.
Each system may still be useful. The problem is the handoffs.
A product change can begin in an experiment, require analytical testing, affect a specification, trigger a supplier review, require a manufacturing update, and create a quality or regulatory action. When the underlying records are disconnected, every handoff requires people to export, re-enter, email, reconcile, or explain information that should remain connected to the product.
That is the legacy-platform problem. It is not simply that software is old. It is that the organization cannot reliably follow its product, evidence, and decisions across the systems where work occurs.
What makes an R&D platform legacy?
A legacy R&D environment is defined by its operating behavior, not its purchase date.
A recently deployed system can behave like a legacy platform if it creates another isolated repository. An older system can remain useful if it has a clear role and participates in reliable, governed workflows.
The warning signs are practical:
- Teams maintain local spreadsheets because the official system cannot represent the work they need to perform.
- A result must be copied manually from an instrument, notebook, or LIMS into another record before a product decision can be made.
- The same material, formula, sample, or product has different identifiers in different systems without a dependable way to connect them.
- A change-control assessment begins with email requests for information that should already be linked to the affected product.
- Quality investigations require people to reconstruct which formula, material lot, process condition, or product revision applies.
- Historical experiments are technically stored but difficult to search, compare, or reuse.
- New AI or analytics initiatives depend on manually curated spreadsheet extracts rather than controlled operational records.
The label on the software does not matter much if these conditions remain true. The organization has data, but it does not have a connected technical record.
Why handoffs create the real cost
Most R&D and product-development work crosses functional boundaries.
R&D develops a formula, material, or product concept. Analytical teams test it. Quality evaluates results against specifications. Manufacturing determines whether it can be produced consistently. Supply assesses raw-material availability and cost. Regulatory or product teams review market requirements. Customer or field feedback informs the next revision.
Each handoff can lose context.
An R&D scientist may send a formulation and test request to QC by email. The laboratory receives the sample but not the full development rationale, target properties, prior results, or relevant process conditions. QC returns a result in a separate system. The product team enters a revised specification elsewhere. Manufacturing receives a PDF or spreadsheet containing the approved version.
The original evidence may still exist. The relationships among the evidence do not.
That creates rework. Teams repeat experiments because prior results cannot be found or compared. They delay change decisions because affected products and records must be identified manually. They struggle to investigate quality events because the product, batch, material, process, test, and approval history live in separate places.
The visible cost is time. The larger cost is weaker decisions made with incomplete context.
Why disconnected modules do not create a platform
Many software stacks appear unified because they are sold under one vendor brand or linked by integrations.
Integration can be valuable. It can move data between systems, reduce duplicate entry, and trigger workflow steps. But integration alone does not establish a usable product record.
A reliable R&D environment needs clear ownership of each record and durable relationships among the records that inform a shared decision.
An ELN may be authoritative for experiments, observations, and development formulations. A LIMS may manage samples, methods, test execution, and results. A QMS may control deviations, CAPAs, documents, and training. ERP may remain authoritative for inventory, purchasing, and financial transactions. PLM may govern released product definitions, controlled revisions, and change impact.
The goal is not to force all of that work into one generic screen.
The goal is to ensure that a formula, material, sample, specification, product revision, batch, quality event, and change record can be connected when a team needs to understand the product’s history or assess its future.
If a user cannot move from a material to the formulas and products that use it, from a failed result to the applicable method and product revision, or from a change request to the evidence and downstream records it affects, the organization still has disconnected modules rather than a working platform.
Formulation and process data expose the gap
Legacy systems often struggle most with formulation-based products because a formula is not a simple list of parts.
It can include ingredients at variable quantities or ranges, supplier-specific grades, intermediates and sub-recipes, process steps, order of addition, temperatures, mixing conditions, target properties, customer variants, regional requirements, and performance evidence.
The relationship between these elements matters.
Changing a resin, pigment, solvent, polymer, additive, fragrance, excipient, or active ingredient may affect product performance, processing behavior, stability, quality requirements, customer claims, regulatory status, cost, and manufacturing instructions. A bill of materials can identify some of the components. It may not preserve the full formulation and process context required to evaluate a change.
The same challenge appears during scale-up.
A formula can perform as intended in a laboratory batch but behave differently when mixing conditions, equipment geometry, batch size, temperature, hold time, or raw-material variation changes. If development and manufacturing records are separate, teams may struggle to determine whether a problem comes from the formula, the material grade, the process, or the interaction among them.
A modern environment should preserve those relationships from development through production and future change control.
Modernization does not mean replacing everything
Replacing every existing system is rarely the right first step.
Organizations should begin by identifying the decisions that repeatedly require cross-functional evidence. Material substitutions, formula revisions, scale-up readiness, supplier qualification, quality investigations, customer requests, and product transfers are common examples.
For each workflow, define the records needed to make a reliable decision. Identify which system owns each record, which identifiers connect the records, where manual re-entry occurs, and where users lose product context.
This exercise often reveals that some systems can remain in place.
An existing LIMS may continue to manage controlled laboratory testing. ERP may remain the right system for inventory, purchasing, and financial records. QMS may continue to govern quality events and procedures. The modernization opportunity is to connect those systems to the R&D and product records that give the data operational meaning.
The question is not, “Which system should replace everything?” It is, “Which product decisions are currently difficult because the relevant evidence cannot be connected?”
How to evaluate a modern R&D platform
A software demonstration should test a real product workflow rather than a feature checklist.
Ask a vendor to follow one material, formula, or product configuration through the organization. The demonstration should show how the system handles a proposed raw-material substitution, formulation revision, failed quality result, supplier change, or scale-up decision.
A credible platform should be able to show:
- The current and prior product or formula revisions
- The material, supplier grade, and related where-used relationships
- Relevant experiments, methods, results, and specifications
- Quality events, approvals, and change history
- Manufacturing or process context where applicable
- The records and evidence required to assess the decision
- How changes and approvals are retained for future review
For a formulation-based organization, ask to see a formula represented as structured data, including ingredient quantities, units, process steps, sub-recipes, specifications, and revision history. Ask how the system handles different supplier grades, customer variants, and manufacturing sites. Ask how a result can be traced back to the formula, sample, method, conditions, and product version that gave it meaning.
This reveals more than a generic feature list can.
AI depends on the records underneath it
AI can help teams search technical history, summarize evidence, identify patterns, recommend experiments, and support decisions.
Its value depends on the data it can interpret.
A system cannot produce reliable answers if formulas are stored as unstructured attachments, material names are inconsistent, sample identities do not connect to product versions, and experimental results lack method or process context. An AI interface may still generate a response. Users may not be able to determine whether the response reflects the real product record.
The foundation comes first: structured data capture, controlled revisions, consistent identifiers, traceable relationships, and governed access to evidence.
Organizations that build this foundation can evaluate AI against real workflows. They can ask whether an assistant helps scientists retrieve comparable experiments, whether a model supports formulation optimization, or whether quality teams can identify related events more quickly. Organizations that skip the foundation tend to remain dependent on manually prepared extracts and limited demonstrations.
A better starting point
Legacy R&D environments become costly when product knowledge cannot move with the work.
The most effective modernization program begins with one repeated decision that currently causes a search for information. Map the product records, evidence, systems, handoffs, and ownership involved. Improve the relationships that allow a user to retrieve the required context. Then expand the model to the next workflow.
The outcome is not necessarily one replacement system.
It is a connected product and R&D record that lets teams understand what changed, what is affected, what evidence supports the decision, and what remains to be done.
That is what modern R&D infrastructure should provide: product knowledge that stays usable from the first experiment through quality review, manufacturing, customer use, and the next change.
.png)
.png)
.png)
